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ABST RACT
Introduction. The impact of inflammatory bowel diseases (IBD) on the quality
of life (QoL) of patients is significant and it has important social and professional
consequences. Materials and methods. We aimed to describe the patients’
perspective regarding the impact of IBD on their overall QoL and to evaluate the
differences between men and women. An observational cross-sectional study,
that included 180 patients with IBD in clinical remission, was conducted. All the
patients completed a number of 3 questionnaires in order to evaluate the general
aspects of their QoL. A separate questionnaire was created regarding genderspecific issues in women with IBD encounter. Also, particular features such as
the incidence of anemia and osteoporosis among IBD patients were documented.
The data obtained were analyzed and compared between the two genderclassified groups. Results. According to the Short Inflammatory Bowel Disease
Questionnaire (SIBDQ), patients had a general perception of a good QoL, but
the impact was higher in women. Fatigue and tiredness were severely perceived
almost to the same degree regardless of their gender, whereas anxiety and
unemployment were more present in men. No significant differences in women
with IBD during the active disease and during disease remission were found.
Conclusions. The overall quality of life of IBD patients is affected in many
aspects, leading to the deterioration of their social and professional lives, for both
men and women, but some aspects remain gender-specific and require a
personalized standard of care.

Introduction
Inflammatory bowel diseases (IBD) have a great
impact on the quality of life (QoL), in both men and
women, and represent a substantial burden on the patient
and the caregivers. The consequences can be observed in
the increased rates of depression, anxiety, chronic fatigue
and reduced workforce participation seen in patients with
Crohn’s disease or ulcerative colitis [1, 2].
The impact of IBD on the QoL is multifaceted, from
direct physical distress because of symptoms, in addition
to psychological impairment, financial burden and low
work productivity [1]. People with IBD frequently require
multidisciplinary care, including mental health care, that
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can help in the development of adaptive coping
mechanisms in order to reduce psychological distress.
Several studies have demonstrated that the QoL is
impaired in these patients in comparison with the general
population [3,4], but only a few evaluated the differences
between men and women. As women are regarded as being
more sensitive to social stigma of having a chronic disease
and being prone to anxiety and depression [5], we tend to
think that women with IBD should be more affected than
men, but are they really so?
In order to answer this question, we aimed to make a
comparison between women and men regarding the impact
of IBD on their overall QoL. We tried to raise physicians’
awareness on the gender-specific aspects women with IBD
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may have and the impact on their self-esteem, resilience
and overall coping mechanisms on the daily basis.

Table 1. Special issues of women with IBD
Questionnaire (SIWIBDQ)

Materials and Methods

1. What was your menarche age?

We conducted an observational cross-sectional study,
that included patients with IBD who attended our
Gastroenterology
and
Interventional
Endoscopy
Department from January 2017 until January 2020.
Patients previously diagnosed with IBD, either
ulcerative colitis or Crohn’s disease, who achieved clinical
remission under treatment with biologic agents, were
included. Patients’ consent for data registration and
subsequent use in clinical research was obtained at the time
of inclusion in the current study, after the approval of the
local ethics committee was obtained. Each patient received
a number of questionnaires regarding their perception on
the overall QoL, using the Short Inflammatory Bowel
Disease Questionnaire (SIBDQ) [6], the degree of chronic
fatigue using the Functional Assessment of Chronic Illness
Therapy-Fatigue Scale (FACIT-F) [7], the level of anxiety
and depression caused by numerous hospital admissions
(HADS) [8] and the impact of the disease on work
productivity. Furthermore, a particular questionnaire was
created for women with IBD specifically, concerning
issues such as menstruation (age of menarche, variations of
menstruation symptoms during remission and active
disease) and the possibility of obtaining a full-term
pregnancy with or without continuing the biologic
treatment, the Special Issues of Women with IBD
Questionnaire (SIWIBDQ) (Table 1).
Nevertheless, the incidence of osteoporosis and anemia
among our patients was also documented from the data
provided by the periodical biological examinations and
bone density scans of each patient.
A total of 180 adult patients achieved sustained clinical
and biochemical remission under biologic treatment. The
data regarding the symptoms and patient-reported
outcomes were gathered using the previously stated
questionnaires, after a minimum of 6 months of persistent
clinical remission. Clinical remission was defined as the
absence of symptoms: resolution of diarrhea and bleeding,
abdominal pain and weight loss. However, laboratory
testing was performed for each patient in order to correlate
clinical with biochemical remission. Laboratory tests
included complete blood count, inflammatory markers (Creactive protein), albumin level and fecal calprotectin
levels. All patients included in this study had no
leukocytosis on complete blood count tests and C-reactive
protein and albumin levels were within normal range. Also,
fecal calprotectin levels were normal.
The exclusion criteria for participation in this study
were pre-existing diagnoses of depression or anxiety
disorder and continuous or intermittent treatment with antidepressant or anti-anxiety medications.

• 12-13 years
• < 12 years
• ≥ 14 years

Points
0
1
2

2. How do you perceive menstruation
symptoms during clinical remission of IBD
versus active disease phase?
• Menstruation symptoms are less severe
• Menstruation symptoms are the same
• Menstruation symptoms are more severe

0
1
2

3. Did you have any pregnancy since the
biological treatment for IBD was initiated?
• No
• Yes

0
1

4. If the answer to question 3 was yes, did you
discontinue the biological treatment during
pregnancy?
• No
• Yes

0
1

Tick the box beside the reply that best describes
your current situation. Please answer all the
questions.
Scoring:
Total score: ______
Normal = 0-3; Abnormal (case) = 4-6.
From a total of 180 patients who met the inclusion
criteria, 65 were women and 115 were men, with an
average age of 37 years. Therefore, two groups were
created based on the gender classification.
All patients included in this study completed the
following questionnaires: (1) Short Inflammatory Bowel
Disease Questionnaire (SIBDQ); (2) Functional
Assessment of Chronic Illness Therapy-Fatigue (FACITF) and (3) Hospital Anxiety and Depression Scale (HADS).
Women also completed the (4) Special issues of women
with IBD Questionnaire (SIWIBDQ).
The SIBDQ is a disease-specific health-related quality
of life (HRQoL) measuring tool, meant to evaluate four
domains – bowel, emotion, social and daily activities, and
general well-being. Its importance lies in the capacity to
address key points in one’s life, such as social life,
psychological well-being, the degree of fatigue, the
presence of depression and body image. The questionnaire
contains 10 items, and each item has a 7-point scale from
1 to 7. The absolute SIBDQ score ranges from 10 to 70,
with higher values suggesting a better QoL.
The Functional Assessment of Chronic Illness Therapy
- fatigue (FACIT-fatigue) scale is an instrument designed
293
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to assess fatigue and tiredness and their impact on daily
activities and functioning in patients with chronic
diseases. This score contains 13 items, each item being
ranked from 0 to 4 points, with a total score of 52 points.
The instrument includes aspects such as tiredness,
weakness, lack of energy, listlessness and the impact of
these feelings on daily activities (for example sleeping
and social activities). A score under 30 points is
representative for severe fatigue and the higher the score,
the better the QoL of patients.
In assessing the QoL of patients included in this study,
a questionnaire consisting of a 7-question anxiety
assessment and 7-question depression assessment, the
HADS score, was also used. The score for each item ranges
from zero to three, with three indicating the highest anxiety
or depression level. A total subscale score of more than 11
points out of 21 possible points suggests considerable
symptoms of depression or anxiety, between 8 and 10
being borderline abnormal, and less than 7 being normal.
In order to fully understand the women-specific issues,
we created the Special Issues of Women with IBD
Questionnaire (SIWIBDQ), consisting of 4 questions
regarding the menarche age, menstruation symptoms
assessment during clinical remission in comparison with
active disease phase and pregnancy (Table 1).
All the data obtained were analyzed and compared
between the two gender-classified groups.

Results
A total of 180 patients were included in this study.
From these, 115 patients were men and 65 women, aged
between 19-47 years, thus balancing the scale towards
men, with a percentage of 63.89%. The majority of the
patients had no other comorbidities (91.67%). Overall,
median SIBDQ, FACIT-F, HADS-anxiety and HADSdepression for males were 53.52, 17.04, 5.21, and 4.56,
respectively, and for women, 52.30, 18.53, 4.69, and 4.07.
the demographic data including patients’ clinical
characteristics are shown in Table 2.
The SIBDQ score
A very useful tool in measuring health-related QoL is
the Short Inflammatory Bowel Disease Questionnaire
(SIBDQ). When asked to fill in the SIBDQ questionnaire,
women included in this study (36.11% from the total of
patients) obtained total scores ranging from 38 and 67
points, with a median score of 52.30 points. Most of the
patients were men (63.89%) and similar results were
observed in this subgroup: their scores varied from 27 to
68 points and the median score was 53.52 points. High
median scores were identified in both subgroups, which
means that the patients had a general perception of good
QoL, but the impact was higher in women who obtained
lower scores than men.
294

The FACIT-F score
The impact of the disease on the perception of fatigue
was evaluated for the 115 male subjects in the study: the
scores in this category of patients varied from 7 to 42, with
a median score of 17.04 points. Women who completed this
questionnaire and graded their symptoms obtained scores
from 9 to 33 points, the median score among them being
18.53 points. Therefore, fatigue and tiredness were severely
perceived by the two groups almost to the same degree.
The HADS score
The HADS score can be divided into two subgroups
HADS-anxiety and HADS- depression. The majority of the
patients in our study were within the normal range, without
significant differences between men and women for both the
HADS-anxiety (78.26% vs. 76.92%) and HADS-depression
(78.26% vs. 84.61%). In the borderline category, we
encountered more women than men (15.38% vs. 4.34%) in
the HADS-anxiety subgroup, whereas in the HADSdepression subgroup there where only men (17.40%). In the
abnormal category there were only 5 patients for the HADSanxiety and 3 patients for HADS-depression. But here, in
comparison, the gender scale is inverted, as more men than
women felt severe anxiety (17.4% men, 7.70% women)
(Table 3) and more women than men felt severe depression
(15.39% vs. 4.34%) (Table 4).
Table 2. Demographic and clinical characteristics of
patients with IBD.
Variables
N = 36
Median age, years
42 (19-47)
Males, n (%)
115 (63.89%)
Females, n (%)
65 (36.11%)
Other comorbidities, n (%)
Diabetes mellitus
5 (2.78%)
Arterial hypertension
10 (5.55%)
None
165 (91.67%)
Unemployment
Males, n (%)
40 (22.23%)
Females, n (%)
25 (13.89%)
Anemia
Present, n (%)
15 (8.33%)
Absent, n (%)
165 (91.67%)
Osteoporosis
Males, n (%)
0 (0%)
Females, n (%)
(8.33%)
Median SIBDQ
Males
53.52
Females
52.30
Median FACIT-F
Males
17.04
Females
18.53
Median HADS-anxiety
Males
5.21
Females
4.69
Median HADS-depression
Males
4.56
Females
4.07
Median SIWIBDQ
1.85

Quality of life in women with inflammatory bowel diseases

Table 3. HADS - anxiety score.
Women percentage

Men percentage

(number of cases)

(number of cases)

Normal

76.92% (50)

78.26% (90)

Borderline
abnormal

15.38% (10)

4.34% (5)

Abnormal

7.70% (5)

17.4% (20)

Total

100% (65)

100% (115)

Table 4. HADS - depression score.
Women percentage

Men percentage

(number of cases)

(number of cases)

Normal

84.61% (55)

78.26% (90)

Borderline
abnormal

0% (0)

17.40% (20)

Abnormal

15.39% (10)

4.34% (5)

Total

100% (65)

100% (115)

Table 5. Menarche and the evaluation of dysmenorrhea
during the active disease
Age of menarche

Number of patients
(percentage)

11 years

15 (23.07%)

12 years

25 (38.48%)

13 years

15 (23.07%)

14 years

10 (15.38%)

Dysmenorrhea during the
active stage of the disease
More painful

5 (7.69%)

Equally painful

55 (84.62%)

Less painful

5 (7.69%)

Pregnancy
No pregnancies

50 (77%)

At least one pregnancy

15 (33%)

Continued biological
treatment during pregnancy

10 (66.60%)

Discontinued biological
treatment during pregnancy

5 (33.40%)

The impact on work activity and daily activities
Regarding the employment status and work
productivity of IBD patients, we observed that more than
one third was unemployed, i.e., more men than women
(22.23% vs. 13.89%). Regarding the work productivity and
the number of hours missed from work due to bowel

problems, the majority (56%) of the patients, all women,
did not miss one single hour from work. Only men (8%)
had missed a few hours from work because of bowel
problems and general malaise.
Special issues of women with IBD and the safety of
biologic agents during pregnancy
Regarding the specific issues of women with IBD such
as menstruation, the mean age of menarche was between
12 and 13 years (61.55%), the same as the one for the
general population [9]. Moreover, we did not find
significant differences in women with IBD between
dysmenorrhea during the active disease and during disease
remission, as 84.62% (55 patients) experienced equally
painful periods (Table 5).
Although 77% of the women did not have any
pregnancy prior to the diagnosis, 23% were able to deliver
a full-term baby without complications, out of which
66.60% continued the biologic treatment during pregnancy
and only 33.40% discontinued it.
Anemia and osteoporosis among IBD patients
The topic of anemia and osteoporosis in patients with
IBD benefits from little attention when analyzing extraintestinal disease complications. In our study, we observed
that 92% of our patients have no anemia, which shows that
the disease is controlled and the patients respond well to
iron treatment, and only 9% of the patients, all women, had
osteoporosis.

Discussions
The results of this study focused on the psychological
impact of IBD, demonstrating that although both men and
women obtained high median scores according to the
SIBDQ questionnaire, therefore having a general
perception of an optimum QoL, the impact was higher for
women, who obtained lower scores in comparison with
men.
A study published in 2020 reports similar results: a
lower QoL among women, compared to men diagnosed
with IBD [10]. These findings correspond to the data
observed in the general population, more precisely a higher
rate of absenteeism from work and a more frequent use of
healthcare services among women compared to men [10,
11]. Another important aspect that contributes to a reduced
QoL is the presence of physical asthenia. Compared to
men, women report a higher frequency and intensity of
physical asthenia. This symptom is independent from the
active state of the disease and the presence or absence of
anemia, one of the causal factors [12-14].
However, a surprising feature pointed out by this study
was that more than one third of the patients (36.1%) are
unemployed, because of various reasons. Even though they
are predominantly young adults, living with IBD is
295
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definitely a challenge because work productivity and
employment prospectors are diminished, both directly by
the symptoms and the complications of the disease, and,
indirectly, by the psychological distress patients have to
cope with, making it difficult to get and, especially, to keep
a workplace.
A study conducted in Norway reports higher rates of
unemployment and sick leave among patients diagnosed
with IBD when compared to the general population [15].
Moreover, the unemployment rate was slightly higher in
women compared to men (12.4% vs. 11.1%) [16]. The
unemployment rate was higher in patients diagnosed with
ulcerative colitis (13.2%) compared to those diagnosed
with Crohn disease (8.7%) [15]. The mean unemployment
age in patients with ulcerative colitis was 55.3 years,
compared to 42.2 years in those with Crohn disease [15].
Even if fatigue and tiredness are more and more present
among the general population due to a constant need to
keep up with each other, especially in the working
environment, it represents a daily burden for IBD patients,
regardless of their gender [16]. According to the FACIT-F
score, both women and men were severely affected,
obtaining similar scores.
Numerous studies show that the QoL is impaired in
these patients in comparison with the general population.
Also, psychological distress does not always correlate with
the activity and severity of the disease, because even during
the clinical remission, patients may experience the
impairment of the QoL [1-4].
Disease chronicity requires the development of selfmanagement and coping skills over time; therefore, it is not
surprising that IBD patients have an increased risk of
mental health issues, including depression, which is an
important problem that patients often experience;
therefore, it is essential for the caregiver to recognize these
diseases in the early stages. Recent studies show that the
relationship between depression and chronic disease is
bidirectional, with poor health leading to poor selfmanagement, as well as poor self-management leading to
poor health [17,18].
The ongoing problem depression and anxiety pose in
IBD patients is outlined by this study by using the HADS
anxiety and depression questionnaire, which showed that
anxiety is more present in men than women, whereas
depression was encountered more predominantly in
women.
In addition to the huge impact that IBD has on the QoL,
people living with IBD face other numerous challenges.
These include social stigma of suffering from a chronic
disease, affordability of medications, diminished
employment prospects, difficulty with leisure time and
travelling, limited community-based supports and
inequitable access to health care specialists and services
[16,18]. Reducing these difficulties should be a priority for
296

physicians and health care providers, to improve the QoL
of their patients.
During flares, symptoms of IBD (both gastrointestinal
and systemic symptoms) disrupt immediate activities and
cause worry and embarrassment to patients. These
immediate effects result in a plethora of impacts on the
patient’s life and psychological well-being, which continue
to have consequences even during the clinical remission of
the disease, but to a lower degree [19].
A 2016 systematic review analyzed 171 studies
including 158,371 individuals and showed a prevalence
rate of anxiety of approximately 20% and a prevalence rate
of depression of 15% in patients with IBD [20]. Both
mental disorders had a higher prevalence during the disease
activity period compared to the remission period. The
estimated anxiety prevalence in patients with IBD during
the disease activity was 75.6%, compared to 20.5% in the
general population. It is noteworthy that the anxiety
prevalence has been shown to be higher in patients with
active IBD compared to patients with diabetes or chronic
obstructive pulmonary disease [20-22]. The estimated
depression prevalence in patients with active disease was
40.7%, compared to 15.2% in the general population.
Depressive disorders have also been diagnosed more
frequently in patients with Crohn disease compared to
those with ulcerative colitis [20].
Interestingly, we found that although both men and
women obtained similar scores, men were more affected
by anxiety, encountered more difficulties getting and,
especially, keeping a workplace, which had a huge impact
on their social life as well.
A key strength of this study was the evaluation of
special issues women with IBD have, despite the
maintenance of remission under biologic agents.
Moreover, by using accessible and easy to understand and
answer questionnaires, we were able to obtain clinical data,
as it is experienced by each patient. An important limitation
of this study is the small number of patients included, but
the data obtained can be a starting point for further larger
prospective multi-center studies.
Although women are more affected by depression and
social stigma than men, they are more resilient and develop
better coping mechanisms, therefore obtaining a better
QoL than men.
These results correspond to the existing data that
highlight the development of better coping mechanisms in
women, compared to men diagnosed with IBD [23,24].
The data so far support a greater negative impact on the
QoL of women with IBD compared to men diagnosed with
the same conditions [25-27].
Nevertheless, we must highlight that, even during the
sustained clinical remission, these patients, regardless of
their gender, experience QoL impairment.

Quality of life in women with inflammatory bowel diseases

Highlights
✓ Inflammatory bowel diseases (IBD) have a great
impact on the quality of life (QoL).
✓ The QoL of patients with IBD is affected in many
aspects, leading to the deterioration of their social and
professional lives, regardless of their gender, even if
the majority of patients regarded themselves as having
a good QoL.
✓ The data show that there are differences between men
and women.

Conclusions
Our study results show that the QoL of patients with
IBD is affected in many aspects, leading to the
deterioration of their social and professional lives,
regardless of their gender, even if the majority of patients
regarded themselves as having a good QoL. Moreover, the
data show that there are differences between men and
women; when asking the question if women are really
more affected than men, we observed that, although
women encounter more difficulties, they have an overall
better QoL than men. Nevertheless, future longitudinal
studies on the psychological impact of patients with IBD
are required in order to help us better understand their
gender-specific needs, create better measurement tools and
improve their QoL.
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